We have licensed regulatory (CE-IVD & US-FDA) approved cancer-specific artificial intelligent applications (AI-apps)
for clinical and research purposes. These include:

Biopsy Tissues: Breast, Colon, Prostate, Metastasis Detection, Tumor Detection.

Cytopathology: Cervical cancer digital screening system.

Biomarkers: H&E, Hormone Receptor, Tissue Type